Coding Is More Than a Reimbursement Detail

Why an effective coding strategy should start early and evolve over time

Coding is often viewed as a tactical reimbursement issue. Identify the appropriate codes, educate providers, and support accurate claims submission. But an effective market access coding strategy goes beyond these activities.

Coding can support payer coverage policy development and the accurate identification of patients, products, diseases, and interventions in claims-based analyses. And because codes can be added, revised, or deleted over time, the approach that works today may not remain appropriate throughout a product’s lifecycle. viewed as a tactical reimbursement issue. Identify the appropriate codes, educate providers, and support accurate claims submission. But an effective market access coding strategy goes beyond these activities, influencing payer coverage decisions, reimbursement processes, and the use of claims data in research and analysis.

During Magnolia Market Access’s recent Navigating Market Access with Magnolia webinar, Cracking the Code: Developing and Implementing Coding Strategies for Your Product, we explored why coding needs to be considered as part of the broader market access strategy.

Knowing which codes exist is only part of the picture. Manufacturers also need to understand how the product will be used, where it will be used, which payers are likely to cover it, what coding options are available, and how those factors may change over time.

Tree icon surrounded by circle graph

Start with how the product will be used

One of the first questions in a coding strategy is where and how the product will be used. A physician-administered drug, medical device, durable medical equipment product, or other technology used in a site of care may require different types of coding depending on where it is used and who is providing the service.

The major coding systems also serve different purposes. HCPCS codes can represent drugs, medical devices, supplies, and certain services. CPT codes describe medical services and procedures. ICD-10-CM codes identify diseases, conditions, symptoms, and other aspects of a patient’s health, while ICD-10-PCS codes identify procedures, services, and treatments provided in facility settings such as inpatient hospitals.

Identifying the relevant code set is only the starting point. Manufacturers also need to understand the anticipated site or sites of care, which customers will need coding information, and which codes may already be available. Those factors help determine what needs to be evaluated as part of the coding strategy.

Tree icon surrounded by circle graph

Payer mix adds another layer

Site of care is only one part of the equation.

Payer type also matters because not every payer recognizes every code in the same way. Some HCPCS code subsets may be recognized across Medicare, Medicaid, and commercial payers, while others may be specific to certain payer types.

Payer mix also needs to be considered alongside site of care. Once manufacturers understand where the product will be used and which payers are likely to cover it, they can better assess which coding options need to be considered and what customers need to understand. The coding needs may differ by site of care and payer type.

Tree icon surrounded by circle graph

An available code is not necessarily the end of the assessment

A new product does not automatically require a new code. At the same time, the existence of an available code does not necessarily mean the coding question has been resolved. Manufacturers may need to evaluate whether existing codes appropriately represent the product or service and, if not, whether a new or revised code should be considered. The assessment can get complicated. Different coding systems are maintained by different entities, and application requirements vary by the type of code being requested. Even within the same entity, different applications can have different requirements.

Depending on the code, the evaluation may include existing coding options, regulatory status, published evidence, utilization, site of care, and how the product is currently being reported.

Experience with the coding application process also matters. The information needed, and how it needs to be presented, depends on the entity reviewing the request and the type of code being considered.

Tree icon surrounded by circle graph

Coding timelines can become launch considerations

Coding pathways can take time. Some coding decisions can occur within months, while others may require a considerably longer runway. Certain applications may also depend on FDA approval or clearance before they can move forward.

Those timelines make early planning important. Manufacturers need to understand whether a new or revised code may be needed, what could be required to pursue it, and how the timing fits with broader launch and market access planning.

Tree icon surrounded by circle graph

Coding accuracy matters at the claim level

Coding strategy also has a practical role in identifying potential issues once a product is in the market.

During the webinar, we examined a payer coverage policy in which the diagnosis codes listed within the policy did not appear to fully align with the indications of the treatment outlined in the coverage policy.

The reason for the discrepancy was not known. The published policy may not have included all applicable codes, or the wrong diagnosis codes had been incorporated into claims processing.

Without an understanding of the relevant codes, a discrepancy like this could be missed and may affect how a claim is processed.

Tree icon surrounded by circle graph

Today’s code may not tell yesterday’s story

Coding also matters when manufacturers look back at what happened in the real world. Claims data can support patient selection, patient journey analyses, treatment pathway research, comparative effectiveness studies, budget impact models, predictive models, and other HEOR and RWE applications. But claims-based research depends on accurately identifying what occurred during the period being studied.

Codes change. A product may be reported under one code during one period and another code later. During the webinar, for example, we discussed how Medicare utilization for a product with pass-through status may initially appear under a C code before transitioning to a J or Q code.

Looking only for the code in use today could create an incomplete picture of historical utilization. The same issue can apply to diagnoses, procedures, and other interventions included in a claims-based analysis.

When a study looks back several years, understanding the coding history across that period is critical to identifying the appropriate data.

Tree icon surrounded by circle graph

AI can support coding research, but its findings still need to be checked

AI can be a useful place to start when researching coding, but its findings still need to be checked. During the webinar, a general-purpose AI tool was asked whether there was a modifier for reporting compliance with an FDA-mandated REMS program. The tool did not identify an existing code, even though there was a HCPCS modifier that was publicly available through multiple, authoritative coding sources.

That does not mean AI has no role in coding. Coding-specific AI platforms are already being used in healthcare settings to assist with medical records documentation and appropriate code identification. But relying completely on a general-purpose AI tool as the sole source of truth still carries risk. Coding findings still need to be checked against current, authoritative sources.

Tree icon surrounded by circle graph

Coding strategy should continue after launch

Obtaining a code is not the end of the coding strategy. Codes can be added, revised, or deleted. Needs can vary by site of care and payer type. Coding information incorporated into reimbursement resources, customer education, internal training, and study protocols can therefore become outdated.

Manufacturers need to monitor coding changes and update their approach when needed. Internal teams and external customers also need to understand the coding options available for the product. Claims-based study protocols need to account for coding changes over time as well.

A claim submitted today may become part of a claims analysis several years from now. That connection between reimbursement today and research later is another reason coding needs ongoing attention.

Coding is more than a reimbursement detail. It needs to remain part of the market access strategy as the product and coding environment evolve.

Tree icon surrounded by circle graph

Is your coding strategy keeping pace with your product?

Whether you are preparing for launch, evaluating existing coding options, or assessing the impact of coding changes, the right approach depends on the product, site of care, payer mix, and coding pathway. Connect with Magnolia Market Access to discuss your product’s coding strategy.